GHP Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2M Buy
118,345
+2,423
+2% +$284K 0.56% 59
2026
Q1
$13.9M Buy
115,922
+1,925
+2% +$222K 0.57% 57
2025
Q4
$12M Buy
113,997
+387
+0.3% +$36.3K 0.49% 69
2025
Q3
$9.54M Sell
113,610
-3,439
-3% -$283K 0.4% 84
2025
Q2
$9.27M Sell
117,049
-3,810
-3% -$303K 0.41% 83
2025
Q1
$10.8M Sell
120,859
-1,161
-1% -$108K 0.52% 64
2024
Q4
$12.1M Sell
122,020
-1,323
-1% -$136K 0.57% 55
2024
Q3
$14M Buy
123,343
+1,706
+1% +$203K 0.64% 41
2024
Q2
$15.1M Buy
121,637
+317
+0.3% +$40.8K 0.75% 30
2024
Q1
$16M Buy
121,320
+1,341
+1% +$165K 0.79% 26
2023
Q4
$13.1M Buy
119,979
+2,435
+2% +$253K 0.71% 34
2023
Q3
$12.2M Buy
117,544
+1,324
+1% +$143K 0.74% 31
2023
Q2
$12.5M Buy
116,220
+4,695
+4% +$533K 0.73% 32
2023
Q1
$11.9M Buy
111,525
+1,964
+2% +$212K 0.75% 24
2022
Q4
$12.2M Buy
109,561
+1,929
+2% +$197K 0.82% 20
2022
Q3
$9.27M Buy
107,632
+3,643
+4% +$325K 0.71% 29
2022
Q2
$9.48M Buy
103,989
+2,944
+3% +$261K 0.7% 33
2022
Q1
$8.29M Buy
101,045
+4,208
+4% +$332K 0.55% 48
2021
Q4
$7.42M Buy
96,837
+1,348
+1% +$107K 0.53% 64
2021
Q3
$7.17M Buy
95,489
+8,758
+10% +$666K 0.57% 56
2021
Q2
$6.75M Sell
86,731
-2,160
-2% -$161K 0.54% 62
2021
Q1
$6.54M Buy
88,891
+5,497
+7% +$405K 0.57% 57
2020
Q4
$6.51M Buy
83,394
+6,840
+9% +$523K 0.62% 53
2020
Q3
$6.06M Buy
76,554
+16,522
+28% +$1.29M 0.69% 46
2020
Q2
$4.43M Buy
60,032
+8,816
+17% +$664K 0.55% 63
2020
Q1
$3.76M Buy
51,216
+2,483
+5% +$195K 0.57% 58
2019
Q4
$4.23M Buy
48,733
+1,133
+2% +$93.1K 0.45% 70
2019
Q3
$3.82M Sell
47,600
-281
-0.6% -$22.5K 0.48% 69
2019
Q2
$3.83M Buy
47,881
+2,408
+5% +$184K 0.47% 71
2019
Q1
$3.61M Buy
45,473
+3,239
+8% +$242K 0.47% 70
2018
Q4
$3.08M Buy
42,234
+12,086
+40% +$853K 0.46% 72
2018
Q3
$2.04M Sell
30,148
-206
-0.7% -$13.1K 0.27% 117
2018
Q2
$1.76M Buy
30,354
+2,274
+8% +$128K 0.25% 126
2018
Q1
$1.46M Buy
28,080
+146
+0.5% +$7.88K 0.21% 148
2017
Q4
$1.5M Buy
27,934
+207
+0.7% +$11.5K 0.21% 139
2017
Q3
$1.69M Buy
27,727
+1,028
+4% +$62.3K 0.26% 119
2017
Q2
$1.63M Sell
26,699
-949
-3% -$57.8K 0.26% 113
2017
Q1
$1.68M Buy
27,648
+157
+0.6% +$9.53K 0.29% 107
2016
Q4
$1.54M Buy
27,491
+3,278
+14% +$192K 0.29% 105
2016
Q3
$1.44M Buy
24,213
+81
+0.3% +$4.74K 0.29% 101
2016
Q2
$1.33M Buy
24,132
+1,068
+5% +$56.8K 0.29% 102
2016
Q1
$1.16M Buy
23,064
+1,134
+5% +$55.5K 0.26% 106
2015
Q4
$1.1M Buy
21,930
+6,433
+42% +$324K 0.27% 101
2015
Q3
$730K Buy
15,497
+2,353
+18% +$125K 0.19% 143
2015
Q2
$720K Buy
13,144
+4,546
+53% +$255K 0.18% 146
2015
Q1
$472K Buy
8,598
+669
+8% +$37.9K 0.12% 179
2014
Q4
$430K Buy
7,929
+537
+7% +$29.9K 0.12% 188
2014
Q3
$418K Buy
7,392
+669
+10% +$37.6K 0.12% 182
2014
Q2
$371K Buy
6,723
+318
+5% +$17.3K 0.11% 198
2014
Q1
$347K Buy
6,405
+784
+14% +$40.6K 0.11% 196
2013
Q4
$268K Buy
5,621
+307
+6% +$14K 0.09% 215
2013
Q3
$241K Buy
+5,314
New +$243K 0.09% 225

Other funds holding MRK

GHP Investment Advisors's MRK Position: Q2 2026 in Review

GHP Investment Advisors increased its Merck (MRK) stake by 2.1% in Q2 2026, buying an estimated $284K and bringing the position to 118,345 shares worth $15.2M. The position accounts for 0.56% of the portfolio, ranked #59.

GHP Investment Advisors first reported a position in MRK in Q3 2013 and has held it in 52 quarters since. The position peaked at $16M in Q1 2024. 1,766 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GHP Investment Advisors held 118,345 shares of Merck worth $15.2M as of Q2 2026.
  • GHP Investment Advisors bought 2,423 Merck shares in Q2 2026, an estimated $284K.
  • Merck made up 0.56% of GHP Investment Advisors's portfolio in Q2 2026, its #59 holding.
  • GHP Investment Advisors first reported a position in Merck in Q3 2013 and has held it in 52 quarters since.
  • GHP Investment Advisors's Merck position peaked at $16M in Q1 2024.
  • 1,766 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.